Agilent Technologies Current Ratio 2010-2025 | A
Current and historical current ratio for Agilent Technologies (A) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Agilent Technologies current ratio for the three months ending April 30, 2025 was 2.09.
| Agilent Technologies Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-04-30 | $4.21B | $2.01B | 2.09 |
| 2025-01-31 | $4.11B | $1.87B | 2.20 |
| 2024-10-31 | $3.96B | $1.90B | 2.09 |
| 2024-07-31 | $4.26B | $2.39B | 1.78 |
| 2024-04-30 | $4.20B | $1.96B | 2.15 |
| 2024-01-31 | $4.34B | $1.62B | 2.68 |
| 2023-10-31 | $4.19B | $1.60B | 2.61 |
| 2023-07-31 | $4.03B | $1.76B | 2.29 |
| 2023-04-30 | $3.95B | $1.67B | 2.37 |
| 2023-01-31 | $4.08B | $1.94B | 2.11 |
| 2022-10-31 | $3.78B | $1.86B | 2.03 |
| 2022-07-31 | $3.69B | $1.90B | 1.94 |
| 2022-04-30 | $3.64B | $1.81B | 2.01 |
| 2022-01-31 | $3.47B | $1.58B | 2.19 |
| 2021-10-31 | $3.80B | $1.71B | 2.22 |
| 2021-07-31 | $3.63B | $1.72B | 2.11 |
| 2021-04-30 | $3.51B | $1.76B | 2.00 |
| 2021-01-31 | $3.48B | $1.69B | 2.07 |
| 2020-10-31 | $3.42B | $1.47B | 2.33 |
| 2020-07-31 | $3.25B | $1.31B | 2.47 |
| 2020-04-30 | $3.17B | $1.95B | 1.63 |
| 2020-01-31 | $3.10B | $1.89B | 1.64 |
| 2019-10-31 | $3.19B | $2.08B | 1.53 |
| 2019-07-31 | $3.46B | $1.62B | 2.13 |
| 2019-04-30 | $3.81B | $1.12B | 3.41 |
| 2019-01-31 | $3.71B | $1.10B | 3.39 |
| 2018-10-31 | $3.85B | $1.17B | 3.29 |
| 2018-07-31 | $3.67B | $1.01B | 3.62 |
| 2018-04-30 | $4.53B | $1.37B | 3.32 |
| 2018-01-31 | $4.40B | $1.36B | 3.23 |
| 2017-10-31 | $4.17B | $1.26B | 3.30 |
| 2017-07-31 | $4.00B | $1.24B | 3.22 |
| 2017-04-30 | $3.80B | $1.19B | 3.20 |
| 2017-01-31 | $3.64B | $1.09B | 3.34 |
| 2016-10-31 | $3.64B | $0.95B | 3.85 |
| 2016-07-31 | $3.53B | $1.15B | 3.07 |
| 2016-04-30 | $3.49B | $1.13B | 3.08 |
| 2016-01-31 | $3.40B | $0.95B | 3.59 |
| 2015-10-31 | $3.69B | $0.98B | 3.78 |
| 2015-07-31 | $3.48B | $0.85B | 4.08 |
| 2015-04-30 | $3.62B | $0.93B | 3.89 |
| 2015-01-31 | $3.65B | $0.93B | 3.94 |
| 2014-10-31 | $5.51B | $1.69B | 3.26 |
| 2014-07-31 | $4.83B | $1.58B | 3.06 |
| 2014-04-30 | $5.38B | $1.72B | 3.13 |
| 2014-01-31 | $5.07B | $1.55B | 3.28 |
| 2013-10-31 | $4.98B | $1.60B | 3.11 |
| 2013-07-31 | $4.58B | $1.55B | 2.96 |
| 2013-04-30 | $4.82B | $1.91B | 2.53 |
| 2013-01-31 | $4.71B | $1.85B | 2.55 |
| 2012-10-31 | $4.63B | $1.89B | 2.45 |
| 2012-07-31 | $4.21B | $2.09B | 2.02 |
| 2012-04-30 | $6.01B | $1.84B | 3.28 |
| 2012-01-31 | $5.72B | $1.71B | 3.35 |
| 2011-10-31 | $5.57B | $1.84B | 3.03 |
| 2011-07-31 | $5.22B | $1.51B | 3.47 |
| 2011-04-30 | $5.10B | $1.59B | 3.20 |
| 2011-01-31 | $4.60B | $1.41B | 3.27 |
| 2010-10-31 | $6.17B | $3.08B | 2.00 |
| 2010-07-31 | $5.74B | $2.92B | 1.97 |
| 2010-04-30 | $5.71B | $2.71B | 2.11 |
| 2010-01-31 | $5.52B | $2.55B | 2.17 |
| 2009-10-31 | $3.96B | $1.12B | 3.53 |
| 2009-07-31 | $2.90B | $0.99B | 2.92 |
| 2009-04-30 | $2.88B | $1.10B | 2.62 |
| 2009-01-31 | $3.01B | $1.13B | 2.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $33.716B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.801B | 26.83 |
| Boston Scientific (BSX) | United States | $156.873B | 37.41 |
| Stryker (SYK) | United States | $150.304B | 30.59 |
| EssilorLuxottica (ESLOY) | France | $143.779B | 0.00 |
| Medtronic (MDT) | Ireland | $118.071B | 16.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.982B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.547B | 24.90 |
| ResMed (RMD) | United States | $41.283B | 29.52 |
| GE HealthCare Technologies (GEHC) | United States | $33.904B | 15.94 |
| Terumo (TRUMY) | Japan | $26.887B | 31.86 |
| Koninklijke Philips (PHG) | Netherlands | $26.663B | 17.64 |
| Insulet (PODD) | United States | $23.536B | 78.86 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.155B | 13.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.315B | 0.00 |
| Baxter (BAX) | United States | $12.599B | 9.73 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.925B | 29.11 |
| Lantheus Holdings (LNTH) | United States | $3.865B | 10.45 |
| Envista Holdings (NVST) | United States | $3.530B | 24.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.295B | 14.62 |
| Perrigo (PRGO) | Ireland | $3.287B | 8.21 |
| ICU Medical (ICUI) | United States | $3.126B | 21.28 |
| Haemonetics (HAE) | United States | $2.651B | 11.83 |
| LeMaitre Vascular (LMAT) | United States | $2.166B | 46.45 |
| Curaleaf Holdings (CURLF) | Canada | $2.148B | 0.00 |
| Acuren (TIC) | United States | $2.126B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.886B | 11.87 |
| Green Thumb Industries (GTBIF) | United States | $1.876B | 80.57 |
| AtriCure (ATRC) | United States | $1.854B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.508B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.305B | 15.41 |
| Neogen (NEOG) | United States | $1.247B | 19.79 |
| AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
| BioLife Solutions (BLFS) | United States | $1.218B | 2543.00 |
| InMode (INMD) | Israel | $0.960B | 8.88 |
| Kestra Medical Technologies (KMTS) | United States | $0.924B | 0.00 |
| Valneva SE (VALN) | France | $0.745B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.699B | 0.00 |
| SNDL (SNDL) | Canada | $0.665B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.611B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.595B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.62 |
| Evolus (EOLS) | United States | $0.490B | 0.00 |
| Surmodics (SRDX) | United States | $0.488B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.475B | 16.36 |
| CeriBell (CBLL) | United States | $0.425B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.380B | 0.00 |
| Owens & Minor (OMI) | United States | $0.378B | 3.35 |
| Canopy Growth (CGC) | Canada | $0.362B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.340B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.302B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.301B | 0.00 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Omeros (OMER) | United States | $0.289B | 0.00 |
| Brainsway (BWAY) | Israel | $0.288B | 58.69 |
| Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 21.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.244B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.214B | 0.00 |
| Exagen (XGN) | United States | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 16.34 |
| FitLife Brands (FTLF) | United States | $0.176B | 21.66 |
| Biote (BTMD) | United States | $0.166B | 5.51 |
| Jushi Holdings (JUSHF) | United States | $0.147B | 0.00 |
| Jin Medical (ZJYL) | China | $0.128B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.66 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.10 |
| Zynex (ZYXI) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.051B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.75 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.45 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Sharps Technology (STSS) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |